Literature DB >> 21559935

Leptin increases prostate cancer aggressiveness.

Constanza M López Fontana1, María E Maselli, Rafael F Pérez Elizalde, Nicolás A Di Milta Mónaco, Ana L Uvilla Recupero, José D López Laur.   

Abstract

Recent studies indicate that adipose tissue and adipocytokines might affect the development of prostate cancer (PCa). Leptin would have a stimulating effect on prostate cancer cells by inducing promotion and progression, whereas adiponectin would have a protective effect. The aim of this study was to determine the relation between body composition, leptin, and adiponectin levels with the prevalence and aggressiveness of PCa in men of Mendoza, Argentina. Seventy volunteers between 50 and 80 years (35 healthy men as control group and 35 with PCa) were selected. The PCa group was subclassified according to the Gleason Score (GS). Digital rectal examination, transrectal ultrasound, and prostatic biopsy were performed; PSA, testosterone, leptin, and adiponectin levels were determined; and a nutritional interview including anthropometric measurements and a food frequency questionnaire was carried out. Statistical analysis was performed by Student t test, ANOVA I, and Bonferroni (p < 0.05). Body mass index and percentage of body fat mass were not statistically different between PCa and control groups. However, body fat mass was higher in subjects with more aggressive tumors (p = 0.032). No differences were observed regarding leptin levels between the groups. Nevertheless, leptin levels were higher in subjects with high GS (p < 0.001). Adiponectin levels showed no statistical differences regarding the presence and aggressiveness of the tumor (p = 0.131). Finally, consumption and nutrient intake did not differ in the studied groups. In conclusion, body composition and leptin are related to the PCa aggressiveness but not with its prevalence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21559935     DOI: 10.1007/s13105-011-0098-y

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  49 in total

1.  Comparison of long-term dietary recall between cancer cases and noncases.

Authors:  L R Wilkens; J H Hankin; C N Yoshizawa; L N Kolonel; J Lee
Journal:  Am J Epidemiol       Date:  1992-10-01       Impact factor: 4.897

2.  Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study.

Authors:  A G Schuurman; P A van den Brandt; E Dorant; H A Brants; R A Goldbohm
Journal:  Cancer       Date:  1999-09-15       Impact factor: 6.860

3.  Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study.

Authors:  A W Hsing; J K McLaughlin; L M Schuman; E Bjelke; G Gridley; S Wacholder; H T Chien; W J Blot
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

4.  Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer.

Authors:  Sabine Rohrmann; William W Roberts; Patrick C Walsh; Elizabeth A Platz
Journal:  Prostate       Date:  2003-05-01       Impact factor: 4.104

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Diet, obesity, and risk of fatal prostate cancer.

Authors:  D A Snowdon; R L Phillips; W Choi
Journal:  Am J Epidemiol       Date:  1984-08       Impact factor: 4.897

7.  Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors.

Authors:  D W West; M L Slattery; L M Robison; T K French; A W Mahoney
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

8.  Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.

Authors:  Stephen J Freedland; William J Aronson; Christopher J Kane; Joseph C Presti; Christopher L Amling; David Elashoff; Martha K Terris
Journal:  J Clin Oncol       Date:  2003-12-22       Impact factor: 44.544

Review 9.  Obesity and prostate cancer: epidemiology and clinical implications.

Authors:  W Cooper Buschemeyer; Stephen J Freedland
Journal:  Eur Urol       Date:  2007-05-02       Impact factor: 20.096

Review 10.  Obesity, metabolic syndrome, and prostate cancer.

Authors:  Ann W Hsing; Lori C Sakoda; Streamson Chua
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

View more
  7 in total

Review 1.  Obesity, energy balance, and cancer: new opportunities for prevention.

Authors:  Stephen D Hursting; John Digiovanni; Andrew J Dannenberg; Maria Azrad; Derek Leroith; Wendy Demark-Wahnefried; Madhuri Kakarala; Angela Brodie; Nathan A Berger
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-03

2.  The diagnostic value of adiponectin multimers in healthy men undergoing screening for prostate cancer.

Authors:  Edward A Medina; Xiaoyu Shi; Marcia H Grayson; Donna P Ankerst; Carolina B Livi; Maria V Medina; Ian M Thompson; Robin J Leach
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-02       Impact factor: 4.254

Review 3.  Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies.

Authors:  Tai Wei; Peng Ye; Xin Peng; Li-Ling Wu; Guang-Yan Yu
Journal:  Oncotarget       Date:  2016-07-26

4.  Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness.

Authors:  Hala Fawzy Mohamed Kamel; Anmar M Nassir; Abeer A Al Refai
Journal:  Cancer Med       Date:  2020-06-23       Impact factor: 4.452

5.  Involvement of the Endocrine-Disrupting Chemical Bisphenol A (BPA) in Human Placentation.

Authors:  Sophie-Christine de Aguiar Greca; Ioannis Kyrou; Ryan Pink; Harpal Randeva; Dimitris Grammatopoulos; Elisabete Silva; Emmanouil Karteris
Journal:  J Clin Med       Date:  2020-02-03       Impact factor: 4.241

6.  Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis.

Authors:  Anya J Burton; Rebecca Gilbert; Kate Tilling; Ryan Langdon; Jenny L Donovan; Jeff M P Holly; Richard M Martin
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

Review 7.  A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus.

Authors:  Danielle Crawley; Florence Chamberlain; Hans Garmo; Sarah Rudman; Björn Zethelius; Lars Holmberg; Jan Adolfsson; Par Stattin; Paul Carroll; Mieke Van Hemelrijck
Journal:  Ecancermedicalscience       Date:  2018-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.